GN Store Nord A/S (OTCMKTS:GNNDY – Get Rating) is one of 149 publicly-traded companies in the “Medical Devices” industry, but how does it contrast to its rivals? We will compare GN Store Nord A/S to similar companies based on the strength of its earnings, analyst recommendations, dividends, valuation, institutional ownership, risk and profitability.
Valuation & Earnings
This table compares GN Store Nord A/S and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| GN Store Nord A/S | $2.51 billion | $279.38 million | 30.74 |
| GN Store Nord A/S Competitors | $997.46 million | $101.02 million | 128.80 |
GN Store Nord A/S has higher revenue and earnings than its rivals. GN Store Nord A/S is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| GN Store Nord A/S | 3.88% | 10.43% | 2.44% |
| GN Store Nord A/S Competitors | -84.70% | -45.43% | -16.17% |
Dividends
GN Store Nord A/S pays an annual dividend of $0.45 per share and has a dividend yield of 0.6%. GN Store Nord A/S pays out 19.2% of its earnings in the form of a dividend. As a group, “Medical Devices” companies pay a dividend yield of 2.2% and pay out 294.5% of their earnings in the form of a dividend.
Insider and Institutional Ownership
34.7% of shares of all “Medical Devices” companies are owned by institutional investors. 24.4% of shares of all “Medical Devices” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Risk & Volatility
GN Store Nord A/S has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, GN Store Nord A/S’s rivals have a beta of 0.91, suggesting that their average stock price is 9% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations for GN Store Nord A/S and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GN Store Nord A/S | 0 | 3 | 6 | 0 | 2.67 |
| GN Store Nord A/S Competitors | 254 | 1076 | 1702 | 89 | 2.52 |
GN Store Nord A/S presently has a consensus price target of $236.50, suggesting a potential upside of 228.81%. As a group, “Medical Devices” companies have a potential upside of 45.49%. Given GN Store Nord A/S’s stronger consensus rating and higher possible upside, analysts clearly believe GN Store Nord A/S is more favorable than its rivals.
Summary
GN Store Nord A/S beats its rivals on 10 of the 15 factors compared.
GN Store Nord A/S Company Profile
GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer technology solutions in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Receive News & Ratings for GN Store Nord A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord A/S and related companies with MarketBeat.com's FREE daily email newsletter.
